NCT01711762View on ClinicalTrials.gov

A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Healthy Volunteer

Interventions

DRUG

GDC-0973

Single oral dose of \[14C\]-GDC-0973

Trial Locations (1)

53704

Madison

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY

NCT01711762 - A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter